Skip to main content
Premium Trial:

Request an Annual Quote

Bayer HealthCare, Applied Biosystems, CombiMatrix


The diagnostics division of Bayer HealthCare has won CE Mark approval for its Trugene HIV-1 genotyping kit. The test, cleared by the US Food and Drug Administration in September 2001, is the first HIV-resistance product to be approved in the European Union under the European Commission’s IVD Directive.

The Trugene assay detects HIV mutations known to make certain antiretroviral drugs ineffective, the company said.

Applied Biosystems has launched a pair of new real-time PCR systems. The tools, the 7300 and 7500 real-time PCR systems, enable researchers to perform gene expression analysis, pathogen quantitation, and SNP genotyping, ABI said. The company added that the systems do not require scientists to run gels, purify PCR products, or perform any post-PCR manipulation.

Both products can run TaqMan Assays-on-Demand or Assays-by-Design for gene-expression analysis or SNP genotyping.

CombiMatrix has rolled out its microarray for the detection of the H5N1 Bird Flu influenza A virus after the World Health Organization on Jan. 27 asked the company for help. The company used its probe-design software to develop the array “within two days” of the WHO’s plea, CombiMatrix said.

The company said its array not only identifies the H5N1 virus, but also enables public health officials to track any mutations that may develop.

Filed under

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.